Geeta Lal, MD, MSc


Endocrine and Breast Oncology Surgeon
Associate Professor of Surgery  - Surgical Oncology and Endocrine Surgery

Contact Information

Primary Office: 4641 JCP
Iowa City, IA 52242
Primary Office Phone: 319-356-1327



BS, Summa cum Laude, McMaster University, Ontario, Canada
MD, Honors, University of Toronto, Ontario, Canada
MSc, University of Toronto and The Samuel Lunenfeld Research Institute, Ontario, Canada

Residency, General Surgery, University of Toronto, Ontario, Canada
Fellowship, Endocrine Surgical Oncology, Mt. Zion Medical Center, University of California, San Francisco

Licensure and Certifications

Iowa Medical License, Iowa Board of Medical Examiners
Board Certified, General Surgery, American Board of Surgery

Research Summary

My lab is interested in studying genetic markers that can be used for diagnosis and in predicting prognosis of thyroid cancer and other endocrine malignancies. We also maintain an endocrine tumor tissue bank. We are also involved in several clinical projects in endocrine surgical oncology.

Selected Publications

Show All

Lal G, Groff  M, Howe  J, Weigel  , Sugg  S, Lynch  C.  Risk of second primary thyroid cancer following another malignancy: Trends in a population-based study.  Ann Surg Oncol .  2012 January. 

Lal G, Spanheimer  P, Sugg  S, Howe  J, Weigel  R.  Surveillance and intervention following thyroid lobectomy.  Ann Surg Oncol .  2011 June. 18(6):1729-33.

Lal G, Fang  S.  Parathyroid cancer.  Endocr Pract.  2011 April. 1:36-43.

Lal G, Weigel  R, Kirby  P, Miron  , Royer  N.  Incidental finding of Composite pheochromocytoma-ganglioneuroma: Successful management after emergent appendectomy and review of the literature..  World Journal of Endocrine surgery .  2011. 3(1):34-44.

Lal G, Clark  O.  Management of Differentiated Thyroid cancers – Updated guidelines from the American Thyroid Association.  2010 December. 

Lal G, Gardner  D, Greenspan  F, Clark  O.  Endocrine Surgery.  McGraw-Hill Companies.  2010. 

Lal G, Fairchild  , Howe  J, Weigel  R, Sugg  S, Menda  Y.  PET-CT for recurrent or persistent differentiated thyroid cancer – Is there added utility beyond conventional imaging? .  Surgery.  2010. 148(6):1082-9.

Lal G, Weigel  , Fang  S, Guidroz  J, O’Malley  , Sugg  , Howe  J.  Expansion of a cell population expressing Stem cell markers in parathyroid glands from patients with Hyperparathyroidism.  Ann Surg.  2010 January. 251(1):107-13.

Lal G, Nowell  A, Liao  J, Sugg  , Weigel  R, Howe  J.  Determinants of survival in patients with calciphylaxis – a multivariate analysis.  Surgery.  2009 December. 146(6):1028-34.

Lal G, Hashimi  , Smith  B, Zhang  L, Lynch  , Robinson  R, Weigel  .  Extracellular Matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer – a hospital-based cohort study in Iowa.  Ann Surg Oncol ;  2009. 

Date Last Modified: 07/31/2013 - 10:51:40